We are excited to announce the launch of a fully differentiated and functional human iPSC-derived Dopaminergic Neurons.

iXCells Human Dopaminergic Neurons are derived from the directed differentiation of iPSC lines using an integration- and footprint-free differentiation protocol resulting in high-purity authentic dopaminergic neurons that mature in a short period of time. These neurons are ideally suited for studies involving control and disease-related dopaminergic neurons produced from iPSC lines in applications for drug and neurotoxicity screening and co-culture studies. 

Product Highlights:

• Ready-to-use, fully differentiated authentic dopaminergic neurons
• Express relevant markers: Characterized by TH, FOXA2, MAP2, DAT, PSD95, Syn1, TUJ1
• High purity: >80% TH positive cells, >90% TUJ1 positive cells                         
• Functionally validated: Electrophysiological activity, release of DA                
• Compatible with a wide range of cell-based assays: toxicity assay, calcium signaling, neurite outgrowth and retraction, co-culture with glia cells  
• Long term culturing viability: more than 60 days in optimized maintenance media. 

You can learn more about this product by clicking here.